Develops ContraBand, a minimally invasive transcatheter implant intended to rebalance hemodynamics in heart failure. Clinical stage, with European feasibility studies running and a US trial in preparation.
One email, every morning
THE MORNING BRIEF
New clearances, funding rounds and regulatory moves for device founders, and every new how-to guide and template as it lands. No noise, no login.
✓
You're in. The next morning brief lands in your inbox.
Unsubscribe anytime. We never sell the list.